Summary

Basal cell and squamous cell carcinomas are the two most common forms of skin cancer, and while both develop from sun-damaged skin, they behave differently and carry different levels of risk. Understanding how they compare gives you the foundation to ask the right questions and move toward confident, informed decisions about your care.

Maybe your doctor mentioned one of these terms at a recent appointment. Maybe you noticed a spot on your skin that won’t quite go away, or you’ve been doing your research after someone close to you received a diagnosis. Whatever brought you here, you’re likely wrestling with names that sound clinical and a little alarming, ‘basal cell carcinoma,’ ‘squamous cell carcinoma,’ and you want to understand what they actually mean before you take your next step.

That’s exactly what this guide is for. We’ll walk you through both cancers clearly, explain how they differ from each other and from melanoma, and cover what treatment actually looks like so you can walk into any appointment prepared and informed.

What Is Basal and Squamous Cell Skin Cancer?

Both are forms of non-melanoma skin cancer that develop from cells within the outer layer of the skin, known as the epidermis. Basal cells sit at the deepest level of that layer, while squamous cells make up the surface. Each cancer takes its name from the cell type where it originates.

These are the two most frequently diagnosed skin cancers. They are distinct from melanoma, which originates in the pigment-producing cells of the skin and tends to behave more aggressively. Knowing which type you are dealing with matters because each one has its own growth pattern, risk profile, and range of treatment options.

How Are Basal Cell and Squamous Cell Carcinomas Different?

The two cancers differ in their cell of origin, how they look, how quickly they grow, and how likely each is to spread beyond the original site. The table below summarizes the key distinctions at a glance.

Feature	Basal Cell Carcinoma (BCC)	Squamous Cell Carcinoma (SCC)
Cell of origin	Basal layer (deepest epidermal layer)	Squamous layer (outer epidermal layer)
Growth speed	Slow	Faster than BCC
Typical appearance	Pearly or flesh-colored bump; may have visible blood vessels	Firm, scaly, or crusted red patch; may ulcerate
Spread risk	Very low	Higher than BCC
Common locations	Face, scalp, neck, ears	Face, ears, lips, backs of hands
Primary cause	Cumulative UV exposure	Cumulative UV exposure
Who is most at risk	Fair-skinned adults with prolonged sun exposure	Fair-skinned adults, also immunocompromised patients

It’s worth noting that even experienced clinicians cannot confirm a diagnosis from visual examination alone. Both cancers can share features with common benign skin conditions, such as seborrheic keratoses or actinic keratoses, and a biopsy is the only way to be certain of what you are looking at. That is not a reason for alarm; it is simply a reason to get evaluated rather than wait and wonder.

Where Do Basal and Squamous Cell Skin Cancers Typically Appear?

Both cancers most commonly develop on areas of the body that accumulate the greatest UV exposure over a lifetime: the face, ears, scalp, neck, and hands. The pattern makes sense when you consider that these are the surfaces most frequently left unprotected day after day, year after year.

Where does basal cell carcinoma most often develop?

BCC appears most frequently on the face, particularly the nose, cheeks, and forehead, as well as the scalp, neck, ears, and shoulders. It rarely develops on areas that receive little sun exposure, which makes consistent sunscreen and sun-protective habits a meaningful factor in long-term risk reduction.

Where does squamous cell carcinoma most often develop?

SCC follows a similar distribution but shows up more frequently on the lips and the backs of the hands than BCC does. It can also arise in areas of chronic skin damage, old scarring, or persistent inflammation, not just in sun-exposed zones. This is a meaningful distinction: SCC can occasionally develop in places that were never particularly sun-exposed if the underlying skin has been repeatedly damaged over time.

What Causes Basal and Squamous Cell Skin Cancers?

The primary cause of both BCC and SCC is cumulative ultraviolet radiation from years of sun exposure. This is not about a single severe sunburn; it is about the total UV dose your skin absorbs across a lifetime. 

Every hour spent outdoors without protection contributes to that accumulation, which is why these cancers appear most often in middle age and beyond, even when someone has generally considered themselves a careful sun avoider.

What other factors can increase your risk?

Beyond sun exposure, several additional factors are associated with elevated risk. Tanning bed use delivers concentrated UV radiation and raises the risk for both cancer types. A personal history of significant sunburns, especially in childhood or adolescence, is also meaningful. Fair skin, light-colored eyes, and naturally lighter hair reflect less UV light, making the skin more susceptible to cumulative damage.

Immune suppression is a particularly important factor for SCC. People living with HIV or those taking immunosuppressant medications after an organ transplant have a substantially higher lifetime risk and should be seen for regular skin evaluations. Prior radiation therapy to a skin area, chronic skin conditions, non-healing wounds or scarring, certain strains of HPV, and long-term arsenic exposure have all been associated with SCC risk in various contexts.

Does skin type affect your risk?

Yes, and in a meaningful way. Skin with less melanin absorbs more UV radiation, which is why fair-skinned individuals develop BCC and SCC at higher rates. That said, people with darker skin tones are not immune. SCC in darker skin tones can present differently and may be diagnosed at a later stage, in part because awareness campaigns have historically focused on lighter-skinned populations. Everyone benefits from periodic skin evaluations regardless of their complexion.

What Are the Treatment Options for Basal and Squamous Cell Skin Cancer?

Several effective treatments exist for both BCC and SCC. The right approach depends on the cancer type, the size and location of the lesion, how deeply it has grown, whether it is a first occurrence or a recurrence, and the overall health of the patient. There is no universal answer, which is why the evaluation that precedes treatment is so important.

Treatment	Best Suited For	Key Consideration
Image-Guided Superficial Radiation Therapy (IG-SRT)	BCC and SCC in patients who prefer or require a non-surgical approach	Uses real-time ultrasound imaging to guide radiation delivery; no incision, no wound care, with a 99.6% cure rate
Mohs Surgery	High-risk or recurrent lesions	High cure rate for BCC and SCC; removes only the cancerous tissue while preserving maximum healthy skin
Excisional Surgery	Smaller, well-defined lesions	Standard surgical approach; requires margin analysis after removal
Electrodesiccation and Curettage (ED&C)	Low-risk, superficial BCCs on the trunk or limbs	Less appropriate for high-risk lesions or areas where cosmetic outcome matters
Cryotherapy	Superficial or early-stage lesions	Not recommended for thicker, nodular, or high-risk lesions
Topical Treatments (Imiquimod, 5-FU)	Superficial BCC only	Not appropriate for invasive cancers; specific use cases only
Systemic Therapies (e.g., Hedgehog pathway inhibitors)	Advanced or metastatic disease	Reserved for cases not manageable with surgical approaches

What’s the Best Treatment Option?

There’s no single “best” treatment. It depends on the cancer type, size, depth, location, and whether it’s a first occurrence or recurrence. For eligible BCC and SCC patients, though, IG-SRT is often the strongest starting point.

Image-guided superficial radiation therapy (IG-SRT) uses real-time ultrasound to confirm tumor depth and target the radiation dose precisely. There’s no cutting, no anesthesia, no wound care, and a 99.6% cure rate for eligible BCC and SCC. Treatment happens over a series of outpatient visits, with same-day return to normal activity. It’s used for BCC and SCC, not melanoma, and is especially useful for tumors near the eyes, nose, lips, or ears, and for patients who aren’t ideal surgical candidates.

Surgery still has its place. Mohs surgery suits high-risk or recurrent lesions needing layer-by-layer margin checks. Excisional surgery works for smaller, well-defined lesions. Topical treatments (imiquimod, 5-FU) are limited to superficial BCC and require strict protocol adherence.

Your dermatologist’s evaluation, not a general guideline, should determine the right path.

When Should You See a Dermatologist About a Suspicious Skin Growth?

If you have noticed a new growth, a sore that has not healed after a few weeks, or a change in a spot you have had for a while, those are all reasons to get evaluated. You do not need to be certain it is cancer before booking an appointment. The point of a skin exam is to get a professional answer so you are not left guessing.

The following signs are worth taking seriously:

• A new growth or bump that was not present a few months ago, particularly on sun-exposed areas of the face, scalp, ears, neck, or hands.
• A sore that bleeds, scabs over, seems to heal, and then returns in the same spot. This cycle is a recognized pattern for both BCC and SCC.
• A spot that itches, feels tender, or has become numb without any obvious explanation, especially if it has been present for several weeks.
• A flat, pale, or scar-like area that appeared without any injury to that part of the skin.
• Any growth near the eyes, nose, ears, or lips that is changing in size, shape, or color.
• A personal or family history of skin cancer, which raises your overall lifetime risk and supports more frequent monitoring.

Ready to Get Evaluated?

At Haber Dermatology, we see patients for full skin evaluations, biopsy consultations, and treatment planning from our Beachwood office. Dr. Haber is a Board Certified Dermatologist and Clinical Professor in the Departments of Dermatology and Pediatrics at Case Western Reserve University School of Medicine. 

He treats children and adults, and brings the kind of clinical depth that allows diagnosis, evaluation, and a treatment discussion to happen in a single appointment rather than across multiple referrals.

If you have a spot you want looked at, or if you have already received a diagnosis and want a thorough conversation about your options, you can book a consultation here. There is no reason to keep waiting for something that can be answered. You can treat your skin cancer and still look great.